Behzad Aghazadeh Acquires WHWK Shares

Behzad Aghazadeh recently bought 38,040 shares of WHWK on June 12, 2026. The transaction did not involve any direct cash outlay, as the shares were acquired at a price of $0.00, possibly as part of a compensation plan or a similar arrangement. WHWK shares were trading at $4.16 at the time of the transaction.

Other Institutional Activity in WHWK

QVT Financial LP holds 4,615,709 shares of WHWK, valued at approximately $15.92 million. OrbiMed Advisors LLC maintains a position of 4,166,000 shares worth about $14.37 million. Suvretta Capital Management, LLC owns 3,700,000 shares with a value of $12.77 million. Acuta Capital Partners, LLC holds 3,410,402 shares valued at $11.77 million. Lastly, Avoro Capital Advisors LLC has 2,849,402 shares worth $9.83 million.

WHWK Stock Snapshot

WHWK shares are trading at $4.16. The company's stock has seen varied institutional interest, with several large funds holding significant stakes. The stock's performance and market position are closely watched by investors and analysts.

Insider Buying and Selling at Whitehawk Therapeutics, Inc.

On June 12, 2026, several insiders, including Caley Castelein, Neil Desai, Emma Reeve, Richard Maroun, Baiteng Zhao, and Behzad Aghazadeh, each acquired 38,040 shares of WHWK. These purchases were made at a price of $0.00, indicating they might have been part of a stock-based compensation plan. None of these transactions were pre-planned under Rule 10b5-1.

Analysts Set New Price Targets

On April 16, 2026, Citizens initiated coverage of WHWK with a 'buy' rating and set a price target of $8.00. Earlier, on December 22, 2025, Jones Trading also initiated coverage with a 'buy' rating and a $7.00 target. The consensus view among analysts is positive, with a general recommendation of 'buy' and a mean price target reflecting optimism about the stock's future.

About WHWK

WHWK operates in a sector that involves [sector/industry not specified]. The company focuses on [business focus not specified]. It is headquartered in [location not specified] and is led by [CEO not specified]. WHWK employs [number of employees not specified] people, working towards its business goals and objectives.

Bottom Line

Behzad Aghazadeh's recent share acquisition in WHWK highlights insider confidence. With the stock trading at $4.16 and analysts setting optimistic price targets, WHWK remains a stock to watch. Institutional holdings reflect strong interest, although investors should remember that insider purchases can be part of planned compensation rather than market-driven decisions.